InRetail set for swift return via pharma arm
Peruvian retail group InRetail is set to send a subsidiary to bond markets for the second time in a month as its pharmacy arm InRetail Pharma plots a $550m debut issuance.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: